Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation.
Identifieur interne : 002064 ( PubMed/Checkpoint ); précédent : 002063; suivant : 002065Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation.
Auteurs : Subramanian Swaminathan [Inde] ; Vanamail Perumal ; Srividya Adinarayanan ; Krishnamoorthy Kaliannagounder ; Ravi Rengachari ; Jambulingam PurushothamanSource :
- PLoS neglected tropical diseases [ 1935-2735 ] ; 2012.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Animaux, Antigènes d'helminthe (sang), Enfant, Enfant d'âge préscolaire, Femelle, Filaricides (administration et posologie), Filariose lymphatique (traitement médicamenteux), Filariose lymphatique (épidémiologie), Humains, Inde (épidémiologie), Jeune adulte, Mâle, Nourrisson, Nouveau-né, Prévalence, Recherche sur les services de santé, Sujet âgé, Sujet âgé de 80 ans ou plus, Surveillance pharmacologique, Traitement médicamenteux ().
- MESH :
- administration et posologie : Filaricides.
- sang : Antigènes d'helminthe.
- traitement médicamenteux : Filariose lymphatique.
- épidémiologie : Filariose lymphatique, Inde.
- Adulte, Adulte d'âge moyen, Animaux, Enfant, Enfant d'âge préscolaire, Femelle, Humains, Jeune adulte, Mâle, Nourrisson, Nouveau-né, Prévalence, Recherche sur les services de santé, Sujet âgé, Sujet âgé de 80 ans ou plus, Surveillance pharmacologique, Traitement médicamenteux.
- Wicri :
- geographic : Inde.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Animals, Antigens, Helminth (blood), Child, Child, Preschool, Drug Monitoring, Drug Therapy (methods), Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (epidemiology), Female, Filaricides (administration & dosage), Health Services Research, Humans, India (epidemiology), Infant, Infant, Newborn, Male, Middle Aged, Prevalence, Young Adult.
- MESH :
- chemical , administration & dosage : Filaricides.
- chemical , blood : Antigens, Helminth.
- geographic , epidemiology : India.
- drug therapy : Elephantiasis, Filarial.
- epidemiology : Elephantiasis, Filarial.
- methods : Drug Therapy.
- Adult, Aged, Aged, 80 and over, Animals, Child, Child, Preschool, Drug Monitoring, Female, Health Services Research, Humans, Infant, Infant, Newborn, Male, Middle Aged, Prevalence, Young Adult.
Abstract
Monitoring and evaluation guidelines of the programme to eliminate lymphatic filariasis require impact assessments in at least one sentinel and one spot-check site in each implementation unit (IU). Transmission assessment surveys (TAS) that assess antigenaemia (Ag) in children in IUs that have completed at least five rounds of mass drug administration (MDA) each with >65% coverage and with microfilaria (Mf) levels <1% in the monitored sites form the basis for stopping the MDA. Despite its rigour, this multi-step process is likely to miss sites with transmission potential ('hotspots') and its statistical assumptions for sampling and threshold levels for decision-making have not been validated. We addressed these issues in a large-scale epidemiological study in two primary health centres in Thanjavur district, India, endemic for bancroftian filariasis that had undergone eight rounds of MDA.
DOI: 10.1371/journal.pntd.0001926
PubMed: 23209865
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:23209865Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation.</title><author><name sortKey="Swaminathan, Subramanian" sort="Swaminathan, Subramanian" uniqKey="Swaminathan S" first="Subramanian" last="Swaminathan">Subramanian Swaminathan</name><affiliation wicri:level="1"><nlm:affiliation>Vector Control Research Centre, Indian Council of Medical Research, Indira Nagar, Pondicherry, India. ssubra@yahoo.com</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Vector Control Research Centre, Indian Council of Medical Research, Indira Nagar, Pondicherry</wicri:regionArea><wicri:noRegion>Pondicherry</wicri:noRegion></affiliation></author><author><name sortKey="Perumal, Vanamail" sort="Perumal, Vanamail" uniqKey="Perumal V" first="Vanamail" last="Perumal">Vanamail Perumal</name></author><author><name sortKey="Adinarayanan, Srividya" sort="Adinarayanan, Srividya" uniqKey="Adinarayanan S" first="Srividya" last="Adinarayanan">Srividya Adinarayanan</name></author><author><name sortKey="Kaliannagounder, Krishnamoorthy" sort="Kaliannagounder, Krishnamoorthy" uniqKey="Kaliannagounder K" first="Krishnamoorthy" last="Kaliannagounder">Krishnamoorthy Kaliannagounder</name></author><author><name sortKey="Rengachari, Ravi" sort="Rengachari, Ravi" uniqKey="Rengachari R" first="Ravi" last="Rengachari">Ravi Rengachari</name></author><author><name sortKey="Purushothaman, Jambulingam" sort="Purushothaman, Jambulingam" uniqKey="Purushothaman J" first="Jambulingam" last="Purushothaman">Jambulingam Purushothaman</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:23209865</idno><idno type="pmid">23209865</idno><idno type="doi">10.1371/journal.pntd.0001926</idno><idno type="wicri:Area/PubMed/Corpus">001E24</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001E24</idno><idno type="wicri:Area/PubMed/Curation">001E24</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001E24</idno><idno type="wicri:Area/PubMed/Checkpoint">001E24</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001E24</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation.</title><author><name sortKey="Swaminathan, Subramanian" sort="Swaminathan, Subramanian" uniqKey="Swaminathan S" first="Subramanian" last="Swaminathan">Subramanian Swaminathan</name><affiliation wicri:level="1"><nlm:affiliation>Vector Control Research Centre, Indian Council of Medical Research, Indira Nagar, Pondicherry, India. ssubra@yahoo.com</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Vector Control Research Centre, Indian Council of Medical Research, Indira Nagar, Pondicherry</wicri:regionArea><wicri:noRegion>Pondicherry</wicri:noRegion></affiliation></author><author><name sortKey="Perumal, Vanamail" sort="Perumal, Vanamail" uniqKey="Perumal V" first="Vanamail" last="Perumal">Vanamail Perumal</name></author><author><name sortKey="Adinarayanan, Srividya" sort="Adinarayanan, Srividya" uniqKey="Adinarayanan S" first="Srividya" last="Adinarayanan">Srividya Adinarayanan</name></author><author><name sortKey="Kaliannagounder, Krishnamoorthy" sort="Kaliannagounder, Krishnamoorthy" uniqKey="Kaliannagounder K" first="Krishnamoorthy" last="Kaliannagounder">Krishnamoorthy Kaliannagounder</name></author><author><name sortKey="Rengachari, Ravi" sort="Rengachari, Ravi" uniqKey="Rengachari R" first="Ravi" last="Rengachari">Ravi Rengachari</name></author><author><name sortKey="Purushothaman, Jambulingam" sort="Purushothaman, Jambulingam" uniqKey="Purushothaman J" first="Jambulingam" last="Purushothaman">Jambulingam Purushothaman</name></author></analytic><series><title level="j">PLoS neglected tropical diseases</title><idno type="eISSN">1935-2735</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Animals</term><term>Antigens, Helminth (blood)</term><term>Child</term><term>Child, Preschool</term><term>Drug Monitoring</term><term>Drug Therapy (methods)</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Elephantiasis, Filarial (epidemiology)</term><term>Female</term><term>Filaricides (administration & dosage)</term><term>Health Services Research</term><term>Humans</term><term>India (epidemiology)</term><term>Infant</term><term>Infant, Newborn</term><term>Male</term><term>Middle Aged</term><term>Prevalence</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Animaux</term><term>Antigènes d'helminthe (sang)</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Femelle</term><term>Filaricides (administration et posologie)</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Filariose lymphatique (épidémiologie)</term><term>Humains</term><term>Inde (épidémiologie)</term><term>Jeune adulte</term><term>Mâle</term><term>Nourrisson</term><term>Nouveau-né</term><term>Prévalence</term><term>Recherche sur les services de santé</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Surveillance pharmacologique</term><term>Traitement médicamenteux ()</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Filaricides</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antigens, Helminth</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>India</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Filaricides</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Drug Therapy</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Antigènes d'helminthe</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Filariose lymphatique</term><term>Inde</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Animals</term><term>Child</term><term>Child, Preschool</term><term>Drug Monitoring</term><term>Female</term><term>Health Services Research</term><term>Humans</term><term>Infant</term><term>Infant, Newborn</term><term>Male</term><term>Middle Aged</term><term>Prevalence</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Animaux</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Nourrisson</term><term>Nouveau-né</term><term>Prévalence</term><term>Recherche sur les services de santé</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Surveillance pharmacologique</term><term>Traitement médicamenteux</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Inde</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Monitoring and evaluation guidelines of the programme to eliminate lymphatic filariasis require impact assessments in at least one sentinel and one spot-check site in each implementation unit (IU). Transmission assessment surveys (TAS) that assess antigenaemia (Ag) in children in IUs that have completed at least five rounds of mass drug administration (MDA) each with >65% coverage and with microfilaria (Mf) levels <1% in the monitored sites form the basis for stopping the MDA. Despite its rigour, this multi-step process is likely to miss sites with transmission potential ('hotspots') and its statistical assumptions for sampling and threshold levels for decision-making have not been validated. We addressed these issues in a large-scale epidemiological study in two primary health centres in Thanjavur district, India, endemic for bancroftian filariasis that had undergone eight rounds of MDA.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23209865</PMID><DateCreated><Year>2012</Year><Month>12</Month><Day>04</Day></DateCreated><DateCompleted><Year>2013</Year><Month>04</Month><Day>05</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1935-2735</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>11</Issue><PubDate><Year>2012</Year></PubDate></JournalIssue><Title>PLoS neglected tropical diseases</Title><ISOAbbreviation>PLoS Negl Trop Dis</ISOAbbreviation></Journal><ArticleTitle>Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation.</ArticleTitle><Pagination><MedlinePgn>e1926</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pntd.0001926</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Monitoring and evaluation guidelines of the programme to eliminate lymphatic filariasis require impact assessments in at least one sentinel and one spot-check site in each implementation unit (IU). Transmission assessment surveys (TAS) that assess antigenaemia (Ag) in children in IUs that have completed at least five rounds of mass drug administration (MDA) each with >65% coverage and with microfilaria (Mf) levels <1% in the monitored sites form the basis for stopping the MDA. Despite its rigour, this multi-step process is likely to miss sites with transmission potential ('hotspots') and its statistical assumptions for sampling and threshold levels for decision-making have not been validated. We addressed these issues in a large-scale epidemiological study in two primary health centres in Thanjavur district, India, endemic for bancroftian filariasis that had undergone eight rounds of MDA.</AbstractText><AbstractText Label="METHODOLOGY/PRINCIPAL FINDINGS" NlmCategory="RESULTS">The prevalence and intensity of Mf (per 60 µl blood) were 0.2% and 0.004 respectively in the survey that covered >70% of 50,363 population. The corresponding values for Ag were 2.3% and 17.3 Ag-units respectively. Ag-prevalence ranged from 0.7 to 0.9%, in children (2-10 years) and 2.7 to 3.0% in adults. Although the Mf-levels in the survey and the sentinel/spot check sites were <1% and Ag-level was <2% in children, we identified 7 "residual" (Mf-prevalence ≥ 1%, irrespective of Ag-status in children) and 17 "transmission" (at least one Ag-positive child born during the MDA period) hotspots. Antigenaemic persons were clustered both at household and site levels. We identified an Ag-prevalence of ~1% in children (equivalent to 0.4% community Mf-prevalence) as a possible threshold value for stopping MDA.</AbstractText><AbstractText Label="CONCLUSIONS/SIGNIFICANCE" NlmCategory="CONCLUSIONS">Existence of 'hotspots' and spatial clustering of infections in the study area indicate the need for developing good surveillance strategies for detecting 'hotspots', adopting evidence-based sampling strategies and evaluation unit size for TAS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Swaminathan</LastName><ForeName>Subramanian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Vector Control Research Centre, Indian Council of Medical Research, Indira Nagar, Pondicherry, India. ssubra@yahoo.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perumal</LastName><ForeName>Vanamail</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Adinarayanan</LastName><ForeName>Srividya</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Kaliannagounder</LastName><ForeName>Krishnamoorthy</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Rengachari</LastName><ForeName>Ravi</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Purushothaman</LastName><ForeName>Jambulingam</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>11</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Negl Trop Dis</MedlineTA><NlmUniqueID>101291488</NlmUniqueID><ISSNLinking>1935-2727</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000947">Antigens, Helminth</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005369">Filaricides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2001 Nov;65(5):498-503</RefSource><PMID Version="1">11716104</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2011 Oct;5(10):e1346</RefSource><PMID Version="1">22022627</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Southeast Asian J Trop Med Public Health. 1997 Jun;28(2):308-13</RefSource><PMID Version="1">9444011</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2009 Mar;103(3):262-5</RefSource><PMID Version="1">18809193</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Epidemiol Infect. 1989 Dec;103(3):693-702</RefSource><PMID Version="1">2691270</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Filaria J. 2004 May 5;3(1):3</RefSource><PMID Version="1">15128461</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2009 Aug;14(8):877-84</RefSource><PMID Version="1">19624474</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2010;4(3):e640</RefSource><PMID Version="1">20351776</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Epidemiol Infect. 1989 Dec;103(3):685-92</RefSource><PMID Version="1">2691269</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2009 Aug;14(8):870-6</RefSource><PMID Version="1">19552662</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Wkly Epidemiol Rec. 2011 Aug 26;86(35):377-88</RefSource><PMID Version="1">21887884</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2011 Jun;16(6):748-55</RefSource><PMID Version="1">21395929</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2007 Jun;101(6):555-63</RefSource><PMID Version="1">17374389</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Doct. 2007 Jul;37(3):136-9</RefSource><PMID Version="1">17716494</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Parasitol. 2006 May;22(5):226-33</RefSource><PMID Version="1">16564745</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2011 Aug;105(8):431-7</RefSource><PMID Version="1">21601901</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2008 Oct;79(4):480-4</RefSource><PMID Version="1">18840733</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2001 Nov-Dec;95(6):607-9</RefSource><PMID Version="1">11816431</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Commun Dis. 2006 Mar;38(2):155-9</RefSource><PMID Version="1">17370678</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Wkly Epidemiol Rec. 2010 Sep 17;85(38):365-72</RefSource><PMID Version="1">20853547</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 1994 Sep;51(3):348-55</RefSource><PMID Version="1">7943556</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2006 Mar 25;367(9515):992-9</RefSource><PMID Version="1">16564361</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Trop. 2003 Sep;88(1):11-5</RefSource><PMID Version="1">12943971</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000947" MajorTopicYN="N">Antigens, Helminth</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016903" MajorTopicYN="N">Drug Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004358" MajorTopicYN="N">Drug Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005369" MajorTopicYN="N">Filaricides</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006302" MajorTopicYN="N">Health Services Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC3510097</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>11</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>4</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23209865</ArticleId><ArticleId IdType="doi">10.1371/journal.pntd.0001926</ArticleId><ArticleId IdType="pii">PNTD-D-11-01173</ArticleId><ArticleId IdType="pmc">PMC3510097</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Inde</li></country></list><tree><noCountry><name sortKey="Adinarayanan, Srividya" sort="Adinarayanan, Srividya" uniqKey="Adinarayanan S" first="Srividya" last="Adinarayanan">Srividya Adinarayanan</name><name sortKey="Kaliannagounder, Krishnamoorthy" sort="Kaliannagounder, Krishnamoorthy" uniqKey="Kaliannagounder K" first="Krishnamoorthy" last="Kaliannagounder">Krishnamoorthy Kaliannagounder</name><name sortKey="Perumal, Vanamail" sort="Perumal, Vanamail" uniqKey="Perumal V" first="Vanamail" last="Perumal">Vanamail Perumal</name><name sortKey="Purushothaman, Jambulingam" sort="Purushothaman, Jambulingam" uniqKey="Purushothaman J" first="Jambulingam" last="Purushothaman">Jambulingam Purushothaman</name><name sortKey="Rengachari, Ravi" sort="Rengachari, Ravi" uniqKey="Rengachari R" first="Ravi" last="Rengachari">Ravi Rengachari</name></noCountry><country name="Inde"><noRegion><name sortKey="Swaminathan, Subramanian" sort="Swaminathan, Subramanian" uniqKey="Swaminathan S" first="Subramanian" last="Swaminathan">Subramanian Swaminathan</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002064 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002064 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:23209865
|texte= Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:23209865" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |